| | RAD51D, RAD51L3-RFFL (G325S +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (A209fs +2 more) | Microsatellite (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (S320I +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51L3-RFFL, RAD51D (Q319* +2 more) | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (E318K +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (G315V +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (G315R +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (G200W +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (G304D +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (G304C +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (T323I +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | | Single nucleotide variant (splice acceptor variant) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (Q301* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (R300Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51L3-RFFL, RAD51D (R320fs +1 more) | Deletion (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (R300* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (L295V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (R291H +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (R291C +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (R290W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (D167G +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51L3-RFFL, RAD51D (L278P +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (R275Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (R275W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (W268* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (W268R +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (G265R +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (P262T +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (G146fs +2 more) | Deletion (non-coding transcript variant +1 more) | not provided +2 more | GPathogenic/Likely pathogenic |
| | RAD51L3-RFFL, RAD51D (G258R +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (S257G +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R255K +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (R253* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (T272P +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (I251K +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (H138fs +2 more) | Deletion (non-coding transcript variant +1 more) | Breast and/or ovarian cancer +4 more | GPathogenic/Likely pathogenic |
| | RAD51L3-RFFL, RAD51D (N249D +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (V247L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (splice acceptor variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G242V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (R239Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | |
| | RAD51L3-RFFL, RAD51D (R239G +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (A238T +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (E121fs +2 more) | Duplication (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (R232* +2 more) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +5 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (A231S +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (M227T +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (L224* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice acceptor variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51L3-RFFL, RAD51D (R109W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (R109G +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | | Indel (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (L235fs +2 more) | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (P214L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51L3-RFFL, RAD51D (V212I +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (A210E +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (A210V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | RAD51D, RAD51L3-RFFL (T209P +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (S207L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (S207P +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (V205del +2 more) | Microsatellite (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (V203M +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (G195D +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | | Single nucleotide variant (splice acceptor variant) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R186* +2 more) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (L205F +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51L3-RFFL, RAD51D (E184K +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (Q183* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (V181M +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (M178T +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (Q177L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (R165W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | |
| | | Single nucleotide variant (splice acceptor variant) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Deletion (splice donor variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (Q160* +1 more) | Single nucleotide variant (nonsense +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51L3-RFFL, RAD51D (Q155* +1 more) | Single nucleotide variant (nonsense +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (A152D +1 more) | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (Q151* +1 more) | Single nucleotide variant (nonsense +2 more) | Hereditary breast ovarian cancer syndrome +3 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (L147F +1 more) | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51L3-RFFL, RAD51D (L146F +1 more) | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51L3-RFFL, RAD51D (R145H +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | RAD51L3-RFFL, RAD51D (R145fs +1 more) | Deletion (frameshift variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (R145C +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (S144F +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +4 more | |
| | RAD51D, RAD51L3-RFFL (L141P +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (G140E +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +3 more | |
| | RAD51L3-RFFL, RAD51D (G139R +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51L3-RFFL, RAD51D (N138D +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +3 more | |
| | RAD51L3-RFFL, RAD51D (N138H +1 more) | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (S137Y +1 more) | Single nucleotide variant (intron variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (D136G +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +2 more | |
| | RAD51D, RAD51L3-RFFL (Y134H +1 more) | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 | |
| | RAD51D, RAD51L3-RFFL (V132I +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (N131S +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +1 more | |